Suppr超能文献

人类呼吸微生物组:当前的认识和未来的方向。

The Human Respiratory Microbiome: Current Understandings and Future Directions.

机构信息

Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, and.

Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Stanford, California.

出版信息

Am J Respir Cell Mol Biol. 2023 Mar;68(3):245-255. doi: 10.1165/rcmb.2022-0208TR.

Abstract

Microorganisms colonize the human body. The lungs and respiratory tract, previously believed to be sterile, harbor diverse microbial communities and the genomes of bacteria (bacteriome), viruses (virome), and fungi (mycobiome). Recent advances in amplicon and shotgun metagenomic sequencing technologies and data-analyzing methods have greatly aided the identification and characterization of microbial populations from airways. The respiratory microbiome has been shown to play roles in human health and disease and is an area of rapidly emerging interest in pulmonary medicine. In this review, we provide updated information in the field by focusing on four lung conditions, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, and idiopathic pulmonary fibrosis. We evaluate gut, oral, and upper airway microbiomes and how they contribute to lower airway flora. The discussion is followed by a systematic review of the lower airway microbiome in health and disease. We conclude with promising research avenues and implications for evolving therapeutics.

摘要

微生物定植于人体。肺部和呼吸道曾被认为是无菌的,但却存在着多样的微生物群落以及细菌(细菌组)、病毒(病毒组)和真菌(真菌组)的基因组。扩增子和鸟枪法宏基因组测序技术以及数据分析方法的最新进展极大地促进了气道微生物种群的鉴定和特征描述。呼吸微生物组在人类健康和疾病中发挥作用,是肺部医学领域一个迅速兴起的研究热点。在本综述中,我们通过重点关注哮喘、慢性阻塞性肺疾病、囊性纤维化和特发性肺纤维化这四种肺部疾病,提供该领域的最新信息。我们评估了肠道、口腔和上呼吸道微生物组及其对下呼吸道菌群的贡献。讨论之后,我们对健康和疾病状态下的下呼吸道微生物组进行了系统综述。最后,我们总结了有前景的研究方向和对不断发展的治疗方法的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f7b/9989478/83052c50c762/rcmb.2022-0208TRf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验